SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-002857
Filing Date
2023-02-09
Accepted
2023-02-09 07:02:38
Documents
106
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vnda-20221231.htm   iXBRL 10-K 2329414
2 EX-23.1 vnda12312022ex231.htm EX-23.1 2405
3 EX-31.1 vnda12312022ex311.htm EX-31.1 10765
4 EX-31.2 vnda12312022ex312.htm EX-31.2 10615
5 EX-32.1 vnda12312022ex321.htm EX-32.1 6780
11 vnda-20221231_g1.gif GRAPHIC 4652
12 vnda-20221231_g2.jpg GRAPHIC 31890
13 vnda-20221231_g3.gif GRAPHIC 3959
14 vnda-20221231_g4.jpg GRAPHIC 112170
15 vnda-20221231_g5.jpg GRAPHIC 183529
  Complete submission text file 0001628280-23-002857.txt   10123117

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20221231.xsd EX-101.SCH 65221
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20221231_cal.xml EX-101.CAL 98850
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20221231_def.xml EX-101.DEF 246934
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20221231_lab.xml EX-101.LAB 729451
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20221231_pre.xml EX-101.PRE 495881
100 EXTRACTED XBRL INSTANCE DOCUMENT vnda-20221231_htm.xml XML 1479477
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 23601076
SIC: 2834 Pharmaceutical Preparations